Oligonucleotide-based strategies to reduce gene expression

被引:35
|
作者
Dagle, JM
Weeks, DL [1 ]
机构
[1] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
oligonucleotides; antisense; triplex;
D O I
10.1046/j.1432-0436.2001.690201.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Research on embryonic development and differentiation provides a sensitive, but challenging opportunity to use a variety of techniques designed to modulate gene expression. Changes in the expression of a single gene can alter levels of other genes and provide information on developmentally regulated gene expression pathways. The morphological consequences of altered gene expression can link gene expression to developmental fate. Oligonucleotide-based approaches offer a variety of means to potentially disrupt normal gene expression. The basis for some of these approaches is presented in this review.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [1] Oligonucleotide-based inhibition of embryonic gene expression
    Driver, SE
    Robinson, GS
    Flanagan, J
    Shen, W
    Smith, LEH
    Thomas, DW
    Roberts, PC
    NATURE BIOTECHNOLOGY, 1999, 17 (12) : 1184 - 1187
  • [2] Oligonucleotide-based inhibition of embryonic gene expression
    Samuel E. Driver
    Gregory S. Robinson
    Jean Flanagan
    Wei Shen
    Lois E.H. Smith
    David W. Thomas
    Peter C. Roberts
    Nature Biotechnology, 1999, 17 : 1184 - 1187
  • [3] Oligonucleotide-based gene correction strategies: Applications to neuromuscular and cardiovascular diseases
    Graham, IR
    Beattie, SG
    Hill, VJ
    Dickson, G
    CROATIAN MEDICAL JOURNAL, 2001, 42 (04) : 467 - 472
  • [4] Oligonucleotide-based gene targeting technologies
    Filareto, A
    Del Vecchio, F
    Spitalieri, P
    Sangiuolo, F
    Brunetti, E
    Novelli, G
    MINERVA BIOTECNOLOGICA, 2005, 17 (02) : 65 - 76
  • [5] Oligonucleotide-based strategies to combat polyglutamine diseases
    Fiszer, Agnieszka
    Krzyzosiak, Wlodzimierz J.
    NUCLEIC ACIDS RESEARCH, 2014, 42 (11) : 6787 - 6810
  • [6] Oligonucleotide-based gene therapy for cardiovascular disease
    Morishita, R
    Nakagami, H
    Taniyama, Y
    Matsushita, H
    Yamamoto, K
    Tomita, N
    Moriguchi, A
    Matsumoto, K
    Higaki, J
    Ogihara, T
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (08) : 529 - 534
  • [7] An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases
    Fiszer, Agnieszka
    Olejniczak, Marta
    Switonski, Pawel M.
    Wroblewska, Joanna P.
    Wisniewska-Kruk, Joanna
    Mykowska, Agnieszka
    Krzyzosiak, Wlodzimierz J.
    BMC MOLECULAR BIOLOGY, 2012, 13
  • [8] OLIGONUCLEOTIDE-BASED THERAPEUTICS
    RIORDAN, ML
    MARTIN, JC
    NATURE, 1991, 350 (6317) : 442 - 443
  • [9] Oligonucleotide-based strategies to inhibit human hepatitis C virus
    Martinand-Mari, C
    Lebleu, B
    Robbins, I
    OLIGONUCLEOTIDES, 2003, 13 (06) : 539 - 548
  • [10] OLIGONUCLEOTIDE-BASED THERAPEUTICS
    RIORDAN, ML
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 2 - MEDI